Literature DB >> 10615314

Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma.

A J Winter1, S Taylor, J Workman, D White, J D Ross, A V Swan, D Pillay.   

Abstract

OBJECTIVE: To define risk factors for detection of HIV-1 RNA in semen in men attending the two largest HIV clinics in the West Midlands.
METHODS: 94 HIV-1 seropositive men at any stage of infection donated matched semen and blood samples. 36 subjects (38%) were on no antiretroviral treatment, 12 (13%) were on dual therapy, and 46 (49%) were on three or more drugs. Median CD4 count was 291 cells x 10(6)/l. 87 subjects underwent a urethritis screen (Gram stained urethral smear and culture for gonococcus, and LCR for Chlamydia trachomatis on first pass urine). Quantitative cell free HIV-1 RNA was determined by commercial nucleic acid sequence based assay with a lower detection limit of 800 copies/ml for semen and 400 copies/ml for blood. Independent risk factors for seminal HIV RNA detection were defined by logistic regression.
RESULTS: In univariate analysis, subjects not taking antiretrovirals were 11 times more likely to shed HIV RNA (21/36 (58%) v 6/58 (10%); p < 0.0001). Seven subjects (8%) had urethritis (including one C trachomatis infection). Urethritis was significantly associated with detection of seminal HIV RNA (adjusted OR, 80.2; p = 0.006), as was blood plasma viral load (adj OR, 19.3 per factor 10 increase; p < 0.001) and age (adj OR, 1.16 per 1 year older; p = 0.001). Antiviral treatment status, absolute CD4 and CD8 count, clinical stage, treatment centre, ethnicity, and risk factor were not independent predictors. No subject with undetectable blood viral load had detectable seminal HIV RNA.
CONCLUSION: Asymptomatic urethritis is independently associated with seminal HIV RNA shedding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615314      PMCID: PMC1758225          DOI: 10.1136/sti.75.4.261

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  14 in total

1.  High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

Authors:  P Gupta; J Mellors; L Kingsley; S Riddler; M K Singh; S Schreiber; M Cronin; C R Rinaldo
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Quantification of HIV in semen: correlation with antiviral treatment and immune status.

Authors:  P L Vernazza; B L Gilliam; J Dyer; S A Fiscus; J J Eron; A C Frank; M S Cohen
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

3.  Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases.

Authors:  M C Atkins; E M Carlin; V C Emery; P D Griffiths; F Boag
Journal:  BMJ       Date:  1996-08-10

4.  Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.

Authors:  M S Cohen; I F Hoffman; R A Royce; P Kazembe; J R Dyer; C C Daly; D Zimba; P L Vernazza; M Maida; S A Fiscus; J J Eron
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

5.  Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls.

Authors:  J N Krieger; R W Coombs; A C Collier; S O Ross; C Speck; L Corey
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

6.  Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men.

Authors:  O Bagasra; H Farzadegan; T Seshamma; J W Oakes; A Saah; R J Pomerantz
Journal:  AIDS       Date:  1994-12       Impact factor: 4.177

7.  Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture.

Authors:  J R Dyer; B L Gilliam; J J Eron; L Grosso; M S Cohen; S A Fiscus
Journal:  J Virol Methods       Date:  1996-07       Impact factor: 2.014

8.  Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.

Authors:  D J Anderson; T R O'Brien; J A Politch; A Martinez; G R Seage; N Padian; C R Horsburgh; K H Mayer
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

9.  Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.

Authors:  J J Eron; P L Vernazza; D M Johnston; F Seillier-Moiseiwitsch; T M Alcorn; S A Fiscus; M S Cohen
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

10.  Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission.

Authors:  J N Krieger; R W Coombs; A C Collier; D D Ho; S O Ross; J E Zeh; L Corey
Journal:  J Urol       Date:  1995-09       Impact factor: 7.450

View more
  25 in total

Review 1.  Antiretroviral drug concentrations in semen of HIV-1 infected men.

Authors:  S Taylor; A S Pereira
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

Review 2.  Does antiretroviral therapy prevent HIV transmission to sexual partners?

Authors:  Tahaniyat Lalani; Charles Hicks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

3.  Beliefs about treatments for HIV/AIDS and sexual risk behaviors among men who have sex with men, 1997-2006.

Authors:  Seth C Kalichman; Lisa Eaton; Denise White; Charsey Cherry; Howard Pope; Demetria Cain; Moira O Kalichman
Journal:  J Behav Med       Date:  2007-08-10

4.  Does antiretroviral therapy prevent HIV transmission to sexual partners?

Authors:  Tahaniyat Lalani; Charles Hicks
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

5.  Seminal plasma HIV levels in men with asymptomatic sexually transmitted infections.

Authors:  G Rieg; D M Butler; D M Smith; E S Daar
Journal:  Int J STD AIDS       Date:  2010-03       Impact factor: 1.359

6.  The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy.

Authors:  S T Sadiq; S Taylor; A J Copas; J Bennett; S Kaye; S M Drake; S Kirk; D Pillay; I V D Weller
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

7.  Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies.

Authors:  Gunter Rieg; Roger J Lewis; Loren G Miller; Mallory D Witt; Mario Guerrero; Eric S Daar
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

Review 8.  Global prevalence of Trichomonas vaginalis among female sex workers: a systematic review and meta-analysis.

Authors:  Monirsadat Mirzadeh; Aida Vafae Eslahi; Meysam Olfatifar; Amir Abdoli; Elham Houshmand; Hamidreza Majidiani; Morteza Ghanbari Johkool; Setareh Askari; Sima Hashemipour; Milad Badri
Journal:  Parasitol Res       Date:  2021-06-25       Impact factor: 2.289

9.  HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART.

Authors:  Joseph A Politch; Kenneth H Mayer; Deborah J Anderson
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

10.  Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Habibatou D Agne; Joshua E Stern; Cathy W Critchlow; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS       Date:  2006-04-04       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.